Tweet
Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses and candidate vaccine viruses developed for potential use in human vaccines
WER. 15 October 2010, vol. 85, 42 (pp 413?424)
September 2010
The development of representative influenza A(H5N1) and A(H9N2) candidate vaccine viruses, coordinated by WHO, remains an essential component of the overall global strategy for pandemic preparedness. Comparisons of the candidate vaccine viruses with respect to antigenicity and their relationship to newly emerging viruses are ongoing, and will be updated periodically by WHO. An update of current and completed vaccine clinical trials can be found on WHO website. . . .
full article at: http://www.who.int/wer/2010/wer8542.pdf
<o:p></o:p>
WER. 15 October 2010, vol. 85, 42 (pp 413?424)
September 2010
The development of representative influenza A(H5N1) and A(H9N2) candidate vaccine viruses, coordinated by WHO, remains an essential component of the overall global strategy for pandemic preparedness. Comparisons of the candidate vaccine viruses with respect to antigenicity and their relationship to newly emerging viruses are ongoing, and will be updated periodically by WHO. An update of current and completed vaccine clinical trials can be found on WHO website. . . .
full article at: http://www.who.int/wer/2010/wer8542.pdf
<o:p></o:p>